Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LUMOBRY 0,25 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LUMOBRY 0,25 MG/ML COLIRIO EN SOLUCION

Approved

STANDARD

LUMOBRY 0,25 MG/ML COLIRIO EN SOLUCION

Bausch + Lomb Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 30, 2022
Approval ID: 270e175dad500117
Company: Bausch + Lomb Ireland Limited
Type: Standard

Approval Details

Approval Id: 270e175dad500117
Drug Cima Aemps Name: LUMOBRY 0,25 MG/ML COLIRIO EN SOLUCION
Register Number: 88470
Holder Company Name: Bausch + Lomb Ireland Limited
Marketing Company Name: Bausch & Lomb S.A.
Holder Company Detail Path: /organization/bausch-lomb-ireland-limited
Authorization Date: 2022-12-30
Dosage Form: COLIRIO EN SOLUCIÓN
Dose: 0,25 MG/ML
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Bausch + Lomb Ireland Limited
Company Detail Path: /organization/bausch-lomb-ireland-limited

Company Information

Pharmaceutical Company Name: BAUSCH + LOMB IRELAND LIMITED
Country Name: Ireland
City Name: waterford,country_ie
Address: BAUSCH + LOMB VISION CARE

Active Ingredients

BRIMONIDINA TARTRATO

0,25 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 30, 2022

Approval ID

270e175dad500117

Type

Standard

Back to CIMA-AEMPS Approvals